Pneumonia still fourth leading cause of death in Phl
Pneumonia remains one of the leading causes of mortality in the Philippines, ranking as the country’s fourth leading cause of death and prompting health advocates to urge expanded vaccination, early diagnosis and preventive care.
Data from the Philippine Statistics Authority (PSA) recorded 33,040 deaths attributed to pneumonia from January to November 2024, accounting for 6.6 percent of total registered fatalities during that period.
The figures highlight public health concerns ahead of World Pneumonia Day on Thursday, 12 November, an annual global initiative designed to raise awareness regarding the prevention and treatment of the inflammatory lung infection.
To combat the disease, the Department of Health (DoH) administers pneumococcal conjugate vaccines (PCV) to infants and young children through public health centers under the National Immunization Program.
Preventive efforts have also expanded to protect older demographics. In June 2026, the Health Technology Assessment Council approved government financing for the pneumococcal polysaccharide vaccine (PPSV23) for adults aged 60 and older.
The Philippine Health Insurance Corp. (PhilHealth) provides financial coverage for eligible pneumonia patients requiring hospitalization, including individuals categorized as high-risk cases.
These programs align with broader national initiatives aimed at strengthening primary healthcare and reducing out-of-pocket medical expenses for severe respiratory illnesses.
The World Health Organization (WHO) identifies immunization against pneumococcal disease, Haemophilus influenzae type b, measles, and pertussis as essential interventions for reducing pneumonia incidence.
Global health experts also stress non-pharmaceutical preventive strategies for children, including exclusive breastfeeding for the first six months, adequate nutrition and clean, smoke-free indoor environments.
Additionally, the WHO advocates for fortified primary healthcare infrastructure to ensure patients receive prompt medical evaluations, appropriate antibiotic therapies, and supplemental medical oxygen when clinically indicated.
Health authorities continue to remind the public that early clinical intervention remains vital to reducing preventable deaths from the infection.